In conclusion, we have shown that the patients with brain metastases from GTN were curable with the use of combined systemic combination agent chemotherapy plus intrathecal methotrexate with or without additional surgeries in selected cases.
Once again, the most common approach involved the combined use of pyrimethamine, folinic acid, sulfadiazine, and prednisone although more than two thirds recommended other single or combination agent treatment regimens.
Sirolimus might therefore be a therapeutic option for choroidal neovascularization (NSV) patients that do not respond sufficiently to the established anti-VEGF treatments or may be an excellent combination agent, improving overall outcomes and the intervals between anti-VEGF injections.
Against the Enterobacteriaceae, the β-lactam combination agent piperacillin-tazobactam was generally less active than ceftriaxone.
Thus, we selected CPT-11 as the combination agent to be used with S-1.
NEPA is a new oral single fixed combination agent, containing a highly selective NK1 RA, netupitant with palonosetron.
